Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Current Assets Current Deferred Revenue Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deffered Revenue Notes Payables Operating Leases Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Stock Liabilities Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Cash Flow Statement

Daily Values

Growth Metrics

Organogenesis Holdings (ORGO) Current Taxes (2016 - 2018)

Organogenesis Holdings has reported Current Taxes over the past 4 years, most recently at $700000.0 for Q3 2018.

For Q3 2018, Current Taxes changed N/A year-over-year to $700000.0; the TTM value through Sep 2018 reached $700000.0, changed N/A, while the annual FY2017 figure was $100000.0, N/A changed from the prior year.
Current Taxes for Q3 2018 was $700000.0 at Organogenesis Holdings, up from $475000.0 in the prior quarter.
Over five years, Current Taxes peaked at $700000.0 in Q3 2018 and troughed at $100000.0 in Q4 2017.
A 4-year average of $341666.7 and a median of $300000.0 in 2016 define the central range for Current Taxes.